GSK Faces $489 Million Fine to Settle China Bribery Case

To settle all charges in the fourteen-month long investigation into its China bribery scandal, GlaxoSmithKline was ordered by a China court to pay a $489 million fine. The fine (equal to 3 billion RMB) is a record in China, though GSK is probably relieved it wasn't higher. In addition, Mark Reilly, head of GSK China's operations when the scandal broke, was given a suspended sentence and deported. Four GSK China-national executives were also given suspended sentences. More details.... Stock Symbol: (NYSE: GSK) Share this with colleagues: // //